Welcome to our dedicated page for Inception Growth Acqustn SEC filings (Ticker: IGTAW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IGTAW SEC filings page provides access to regulatory documents for the redeemable warrants of Inception Growth Acquisition Limited and the broader capital structure they are part of. These filings explain how the warrants, common stock, units and rights are structured and how the company manages its timeline to complete a business combination.
Form 8-K current reports are especially important for IGTAW. Multiple 8-K filings describe deposits into the company’s trust account and corresponding extensions of the deadline to complete a business combination, such as extensions from September 13, 2025 to October 13, 2025, from November 13, 2025 to December 13, 2025, and later to February 13, 2026. These documents also restate the trading symbols and confirm that the units, common stock, rights and redeemable warrants trade on OTC Markets Group, Inc.
The definitive proxy statement (DEF 14A) dated September 16, 2025 offers detailed background on prior extensions, amendments to the amended and restated certificate of incorporation, amendments to the investment management trust agreement, and the impact of Nasdaq IM-5101-2. It explains how failure to complete a business combination within 36 months of the IPO registration statement’s effectiveness led to a Nasdaq notice, suspension and delisting, followed by quotation on the OTC Markets.
Form 12b-25 (Notification of Late Filing) for the quarter ended September 30, 2025 provides insight into the company’s periodic reporting, explaining why the Form 10-Q could not be filed by the due date and indicating the anticipated timing within the allowed extension period.
On Stock Titan, these filings are supplemented with AI-powered summaries that highlight the key terms affecting IGTAW and related securities, such as warrant exercise terms, trust account activity, extension mechanics and listing status. Real-time updates from EDGAR, along with simplified explanations of complex documents like proxy statements, 8-Ks and 12b-25 notices, help investors quickly understand how new filings may influence the warrants and the SPAC’s overall structure.
Inception Growth Acquisition Limited is asking stockholders to approve amendments to its charter and trust agreement to extend the deadline to complete a business combination from February 13, 2026 to up to August 13, 2026, in six one‑month steps. For each extra month, the sponsor or its affiliates intend to lend the company an amount equal to $0.075 per public share not redeemed, to be deposited into the trust account and repaid only if a deal closes. Public stockholders may redeem their shares for cash; as of January 16, 2026, the estimated redemption price was about $12.75 per share, based on approximately $2,250,589.54 held in the trust account. If the extensions are fully used and no further redemptions occur, the company estimates a future redemption value of about $13.20 per share. The company’s securities have been delisted from Nasdaq for failing to complete a merger within 36 months and now trade on the OTC Markets, which may limit liquidity. If the extension proposals are not approved and no business combination is completed by February 13, 2026, the company will liquidate the trust and public warrants and rights will expire worthless.
Inception Growth Acquisition Limited filed a current report announcing that it has extended the deadline to complete a business combination. On December 9, 2025, the company deposited $13,242.15 into its Trust Account, which extends the time available to finalize a merger or similar transaction from December 13, 2025 to January 13, 2026. This extension gives the SPAC an additional month to seek and complete a suitable business combination while maintaining funds in trust for shareholders.
Inception Growth Acquisition Limited (IGTA) deposited $13,242.15 into its Trust Account to extend the deadline to complete a business combination from November 13, 2025 to December 13, 2025.
The company also issued a press release, filed as Exhibit 99.1, announcing the extension.
The proxy discloses that stockholders approved proposals to extend the time for Inception Growth Acquisition Ltd (IGTAW) to complete an initial business combination, moving the deadline to October 13, 2025 if fully extended and describing a pathway to a further extension to February 13, 2026 via charter and trust amendments. The company deposited $13,249.65 on June 10, 2025, July 7, 2025 and August 11, 2025 to push the trust termination to September 13, 2025. Each one-month extension requires an aggregate $0.075 per public share contribution to the trust as a loan from the Sponsor, repayable on closing or forgiven if no combination occurs. The filing states the company failed to complete a business combination by December 8, 2024, triggering noncompliance with Nasdaq IM-5101-2, resulting in suspension and delisting from Nasdaq on December 17, 2024, with trading commencing on the OTC Markets the same day. The Sponsor currently owns 42.50% of outstanding shares, and the company flags potential CFIUS review and foreign ownership limitations for U.S. targets.
Inception Growth Acquisition Limited reported that on September 10, 2025 it deposited $13,249.65 into its Trust Account. This payment extends the time the company has to complete a business combination from September 13, 2025 to October 13, 2025, giving it an additional month to seek and close a suitable transaction.
The company’s securities trade on OTC Markets under the symbols IGTAU for units, IGTA for common stock, IGTAW for redeemable warrants exercisable at $11.50 per share, and IGTAR for rights to receive one-tenth of a share of common stock. A press release dated September 12, 2025, was provided as an exhibit describing this extension.
FAQ
What is the current stock price of Inception Growth Acqustn (IGTAW)?
